Gfap Upregulation
Gfap Upregulation - Related Videos
06:39
Bioluminescence Imaging of Heme Oxygenase-1 Upregulation in the Gua Sha Procedure
0 Views •
Cited by 40 •
2009
Gua Sha, traditional Chinese therapeutic skin scraping, causes subcutaneous microvascular blood extravasation. We report a protocol of bioluminescence imaging of HO-1-luciferase transgenic mice to demonstrate that Gua Sha upregulates heme oxygenase-1 (HO-1) in multiple organs.
04:11
Assessing Glucose Uptake in the Motor Neurons of Drosophila Larvae with Upregulated Glucose Metabolism
0 Views •
2025
The video demonstrates a technique for measuring glucose uptake in Drosophila larval motor neurons using a fluorescence resonance energy transfer (FRET)-based intracellular glucose sensor. After dissecting the larvae to expose the ventral nerve cord, the motor neurons are visualized through the fluorescence emitted by the sensor's donor fluorophore. When stimulated with glucose, FRET between the sensor's donor and acceptor fluorophores triggers the emission of fluorescence from the acceptor,...
08:32
Sex Differences in Mouse Hippocampal Astrocytes after In-Vitro Ischemia
0 Views •
Cited by 9 •
2016
Astrocytes are one of the most important key players in the central nervous system (CNS). Here, we are reporting a practical method of sexed hippocampal astrocyte culture protocol in order to study the mechanisms underlying the astrocyte function in male and female neonate pups after in-vitro ischemia.
07:46
Triggering Reactive Gliosis In Vivo by a Forebrain Stab Injury
0 Views •
Cited by 8 •
2015
This article describes a detailed protocol to produce a forebrain stab injury in adult mice. The stab injury induces severe reactive gliosis and glial scar formation which can be subsequently examined by standard immunohistochemistry methods.
10:17
Analysis of Schwann-astrocyte Interactions Using In Vitro Assays
0 Views •
Cited by 6 •
2011
This article intends to describe in stepwise fashion the commonly used in vitro assays used in studying Schwann cell-asrtocyte interactions.
FAQs
GFAP upregulation reflects a coordinated cellular response rather than an isolated change in protein abundance. Activated astrocytes increase GFAP transcription and protein production while remodeling their intermediate-filament cytoskeleton. This remodeling supports changes in astrocyte structure during reactive astrogliosis, making GFAP expression relevant to studies of how nervous-system tissue responds to damage or disease.
Brain or spinal cord injury, inflammation, and neurodegenerative disease are associated with increased GFAP expression. These different conditions can converge on astrocyte activation and reactive astrogliosis, during which the astrocyte cytoskeleton changes. Consequently, GFAP upregulation can serve as a shared cellular response across several forms of neurological stress rather than being limited to one disease process.
GFAP upregulation connects astrocyte activity with structural responses occurring in the central nervous system. Measuring the increase can help identify astrocyte activation and assess neurological damage in experimental or clinical research. Its value therefore extends beyond describing astrocyte biology: it provides a measurable indicator for examining injury responses and disease-associated changes.
Researchers can assess GFAP levels in nervous-system tissue, cerebrospinal fluid, or blood. These sample types support different ways of examining astrocyte activation and neurological damage within research or medical investigations. Comparing GFAP measurements across these settings can help characterize the presence of a response and support biomarker-development studies focused on neurological conditions.
GFAP upregulation supports biomarker development because measurable GFAP levels can reflect astrocyte activation associated with injury, inflammation, or neurodegenerative disease. Investigators can study the protein in tissue, cerebrospinal fluid, or blood to evaluate its usefulness for identifying neurological damage. This makes GFAP relevant when developing indicators of disease-related or injury-related nervous-system responses.
Therapy studies can use GFAP upregulation to examine how a potential treatment relates to astrocyte activation and neurological damage. Measurements in tissue, cerebrospinal fluid, or blood provide research outcomes for tracking these responses within the study design. GFAP analysis therefore links treatment investigation with disease mechanisms, injury responses, and evaluation of biological effects.